UB researchers show first evidence of pharmacogenomic differences in patients' responses to MS drug
BUFFALO, N.Y. - University at Buffalo researchers using the latest computer-assisted technologies of genetic analysis have shown for the first time how a widely used drug for treating multiple sclerosis -- interferon beta (IFN-beta-1a) -- can modulate the expression of particular genes in patients being treated for the disease. ... Their results show that IFN-beta-1a initiates different patterns...Pharmacogenomics could replace 'trial-and-error' with science from the human genome
(MEMPHIS, TENN.--May 27, 2004) The future use of a gene-based technology called pharmacogenomics could lower the cost of health care by decreasing the occurrence of adverse drug effects and increasing the probability of successful therapy. These findings are published by investigators at St. Jude Children's Research Hospital in the May 27 issue of Nature. ... ...According to the authors, the sig...New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
WHITE PLAINS, N.Y., NOV. 5, 2003 -- The latest research shows that some women at very high risk of having a preterm baby may benefit from treatment with a derivative of the hormone progesterone, according to an opinion issued by the American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice and published this month in ACOG's official journal, Obstetrics & Gynecolog...Hot topics in pharmacogenomics
Don't miss the extraordinary opportunity to attend the 2nd annual meeting of the International Society of Pharmacogenomics (ISP), a joint meeting with the Pacific Rim Association for Clinical Pharmacogenetics (PRACPG). Join the experts at the beautiful Biltmore Hotel in downtown Los Angeles for two days of rich presentation and knowledge-sharing.... ...This meeting is a satellite of the 53rd Ann...Most Americans open to pharmacogenomics research
DENVER, Colo. -- Most people are open to the idea of using genetics to improve drug therapies, but they don't fully grasp how it works or how it might affect them....... That's the finding of a national survey aimed at assessing public attitudes toward pharmacogenomics, an area of research aimed at discovering the role genes play in how someone will respond to a certain drug....... The survey, fu...Relapse or remission? Pharmacogenomics draws the fine line
DENVER, CO Shortly after chemotherapy treatment, how does a doctor know if a cancer has responded favorably or not to the treatment, or if a patient is destined to develop drug toxicity--before it is too late? ... ...Recent work in the field of pharmacogenomics is working toward reducing that perplexity and making treatments more individualized for patients. Researchers present their latest adva.... . PRINCETON, N.J., February 12, 2001 -- Orchid BioSciences, Inc. (Nasdaq: ORCH) will present its leading single nucleotide polymorphism (SNP) analysis technology, SNP-IT, at the IBC Pharmacogenomics, SNPs & Genetic Patenting Conference in San Diego on February 13, 2001. For more information on the conference, please visit . . . Who: . Michael Boyce-Jacino, Ph.D., Chief Technology Office...Pharmacogenesis: Postgenomic Drug Discovery Through Developmental Biology
.The holy grail of gene therapy? As the precise link between individual genes.and diseases is still largely unknown, developmental biology is emerging as a.promising technology to identify the functional relationship between specific.genes and disease processes. This powerful technology enables researchers to.select and validate optimal therapeutic targets.. On March 26 and 27 in Boston, Mass...